Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2592 Target Snapshot

Adenosine receptor A2b · SINGLE PROTEIN · Rattus norvegicus

159Compounds
51Assays
4Approved Drugs
128.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P29276. Use UniProt P29276 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P29276 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Adenosine receptor A2b as ChEMBL target CHEMBL2592, mapped to UniProt P29276. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Adenosine receptor A2b
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL2592
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P29276
Adenosine receptor A2b
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Adenosine receptor A2b is the right protein anchor across sources, using UniProt P29276 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAdenosine receptor A2b
UniProt AccessionP29276
Component TypeProtein
Sequence Length332 aa

Adenosine receptor A2b

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Adenosine receptor A2b, mapped to UniProt P29276. Sequence length is 332 aa.

Mapped IDP29276
Review nameAdenosine receptor A2b
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase I
Assay Mix

Activity Type Distribution

IC5028.0
KI96.0
KD4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4205635 9.74 Ki 0.18 Preclinical
CHEMBL456125 9.33 Kd 0.4677 Preclinical
CHEMBL513681 8.66 Kd 2.188 Preclinical
CHEMBL273807 7.89 Ki 12.8 Preclinical
CHEMBL10347 7.86 Kd 13.8 Preclinical
CHEMBL588 7.45 Ki 35.48 Approved
CHEMBL310997 7.24 Ki 57.54 Preclinical
CHEMBL2181976 6.79 Ki 163.0 Preclinical
CHEMBL10873 6.76 Ki 174.0 Preclinical
CHEMBL45244 6.75 Ki 177.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
13
5.5
13
6.0
8
6.5
3
7.0
4
7.5
0
8.0
1
8.5
1
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

FENOLDOPAM
CHEMBL588
Approved 1997
DOPAMINE
CHEMBL59
Approved 1974
Assay Landscape

Assay Landscape

51
Total Assays
32
Tested Compounds
2
Assay Types
Binding — 27 assays, 32 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 14 9 6.5
cell-based format 8 20 5.9
assay format 2 1 7.0
cell membrane format 2 0
organism-based format 1 2 5.9
Functional — 24 assays, 25 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 13 3 8.6
assay format 6 0
cell-based format 5 22 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine